Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

467
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
467
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.1K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

2.6K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
2.6K
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

295
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
295
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

915
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
915

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology, clinical management, and outcomes in patients with eosinophilic granulomatosis with polyangiitis in England: A retrospective observational cohort study.

The journal of allergy and clinical immunology. Global·2026
Same author

Right heart catheterization via hemiazygos-azygos collaterals in the setting of inferior vena cava stenosis.

BMC cardiovascular disorders·2026
Same author

Advancing Cancer Therapy: Nano-Therapeutics for Precision Targeting of the Tumor Microenvironment.

Pharmaceutical nanotechnology·2026
Same author

Smart Stimuli-responsive Nanocarriers in Nanotechnology-based Cancer Diagnosis and Treatment.

Current drug delivery·2026
Same author

Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

Nature medicine·2026
Same author

Association of Body Size and Muscle Grip Strength With Hypertension: A Cross-Sectional Study.

Cureus·2026

Related Experiment Video

Updated: May 17, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

Essential database resources for modern drug discovery.

Saloni Yadav1, Sweta S Koka1, Priya Jain2

  • 1Acropolis Institute of Pharmaceutical Education & Research, Indore, Madhya Pradesh, India.

Advances in Pharmacology (San Diego, Calif.)
|April 2, 2025
PubMed
Summary
This summary is machine-generated.

Essential drug discovery databases like PubChem and ChEMBL provide critical data for target selection and screening. Integrating this information with AI accelerates the development of effective new medicines.

Keywords:
Chemical and biological databasesData mining in drug discoveryDrug discovery databasesPharmaceutical informaticsVirtual screening tools high-throughput screening (HTS)

More Related Videos

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

473
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.2K

Related Experiment Videos

Last Updated: May 17, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

473
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.2K

Area of Science:

  • Pharmaceutical Sciences
  • Bioinformatics
  • Computational Chemistry

Background:

  • Drug discovery demands efficient access to comprehensive databases for researchers and pharmaceutical professionals.
  • Key stages in drug development, including target selection, chemical screening, and clinical trial management, rely heavily on curated data resources.

Purpose of the Study:

  • To elucidate the critical role of essential databases in modern drug discovery.
  • To highlight the specific contributions of major databases such as PubChem, ChEMBL, and DrugBank.
  • To explain how integrating data from these resources with computational tools enhances the drug development pipeline.

Main Methods:

  • Review and synthesis of information on prominent drug discovery databases.
  • Explanation of data types and applications for PubChem, ChEMBL, and DrugBank.
  • Discussion of the integration of artificial intelligence (AI) and machine learning (ML) with database resources.

Main Results:

  • PubChem offers extensive chemical structure and biological activity data.
  • ChEMBL provides a curated database of bioactive molecules with drug-like properties.
  • DrugBank details drug interactions, targets, and mechanisms of action.
  • Combined data analysis using AI/ML improves decision-making and accelerates drug candidate identification.

Conclusions:

  • Key databases are indispensable tools in the contemporary drug discovery and development process.
  • The strategic utilization of databases like PubChem, ChEMBL, and DrugBank significantly aids in identifying potential drug candidates.
  • Integration with advanced computational methods like AI and machine learning is crucial for optimizing efficiency and success rates in pharmaceutical research.